Vivekanand Jha's Publications

About Vivekanand Jha's Publications

Executive Director, The George Institute for Global Health, India
  • PHD

  • Perspectives on early detection of chronic kidney disease: the facts, the questions, and a proposed framework for 2023 and beyond

    Kidney International Date published:

  • Trends and perspectives for improving quality of chronic kidney disease care: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International Date published:

  • Challenges in the management of the kidney allograft: from decline to failure: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

    Kidney International Date published:

  • Rituximab in Patients With Primary Membranous Nephropathy With High Immunologic risk

    Kidney International Reports Date published:

  • Wisdom of the Crowd: insights gained from comparing predicted and observed effects of blood pressure lowering strategies

    Journal of Human Hypertension Date published:

  • Defining myocardial infarction in trials of people receiving hemodialysis: consensus report from the SONG-HD MI Expert Working group

    Kidney International Date published:

  • Urinary exosomal miRNA-663a shows variable expression in diabetic kidney disease patients with or without proteinuria

    Scientific Reports Date published:

  • PROphylaxis for paTiEnts at risk of COVID-19 infecTion (PROTECT-V)

    Trials Date published:

  • Community acquired and hospital acquired AKI - two diseases divided by a common definition

    Current Opinion in Nephrology & Hypertension Date published:

  • Kidney and Cardiovascular Effects of Canagliflozin According to Age and Sex: A Post Hoc Analysis of the CREDENCE Randomized Clinical Trial

    American Journal of Kidney Diseases Date published:

  • International Society of Nephrology first consensus guidance for preclinical animal studies in translational nephrology

    Kidney International Date published:

  • The ASCEND-NHQ randomized trial found positive effects of daprodustat on hemoglobin and quality of life in patients with non-dialysis chronic kidney disease

    Kidney International Date published:

  • WCN23-0069 EFFICACY AND SAFETY OF REDUCED-DOSE ORAL METHYLPREDNISOLONE IN IGA NEPHROPATHY: THE TESTING TRIAL

    Kidney International Reports Date published:

  • WCN23-0200 PREVALENCE AND TREATMENT PATTERNS OF ANAEMIA IN INDIVIDUALS WITH CHRONIC KIDNEY DISEASE ACROSS ASIA

    Kidney International Reports Date published:

  • WCN23-1128 Allopurinol for CVD in CKD (AvoiD-CKD): Baseline characteristics from a double blind, randomized controlled trial

    Kidney International Reports Date published:

  • WCN23-0955 Performance of latest eGFR equations in Indian population

    Kidney International Reports Date published: